BVMF/VRTX34 (BVMF/VRTX34)

Brazil Stock Exchange: BVMF/VRTX34 · BRL

R$86.5

+3.68 (+4.4%)· Recorded snapshot

Market cap	701.6B
Revenue (ttm)	65.2B
Net income (ttm)	22.8B
EPS (ttm)	R$2.87
P/E (trailing)	30.1x
P/E (forward)	28.8x
Volume	126
Beta	0.28

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 65.2B
Net income (ttm): 22.8B
EPS (ttm): R$2.87
P/E (trailing): 30.1x
P/E (forward): 28.8x
Market cap: 701.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E28.8

P25 n/aP50 n/aP75 n/a

Trailing P/E30.1

P25 n/aP50 n/aP75 n/a

ROE23.5

P25 n/aP50 n/aP75 n/a

ROIC28.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/VRTX34 indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-02
Employees	6,400
Employees change	700
Employees growth	12.96%
Enterprise value	BRL 639.2B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1989
Industry	Biotechnology
Is primary listing	No
ISIN number	BRVRTXBDR001
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split date	2026-07-27
Last stock split type	Forward
Market cap	BRL 701.6B
Next earnings date	2026-11-02
Price	BRL 86.48
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-26
Symbol	bvmf/VRTX34
Website	https://www.vrtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	50.03x
Average P/E ratio (3Y)	28.04x
Average P/E ratio (5Y)	26.01x
Earnings yield	3.32%
EV/Earnings	28.21x
EV/EBIT	24.52x
EV/EBITDA	22.32x
EV/FCF	32.73x
EV/Sales	9.57x
FCF / EV yield	3.05%
FCF yield	2.79%
Forward P/E	28.82x
Graham number	28.60855
Graham upside	-67.13%
Lynch fair value	BRL 48.40
Lynch upside	-44.39%
P/(FCF - SBC) ratio	43.87x
P/(OCF - SBC) ratio	37.82x
P/B ratio	6.73x
P/E ratio	30.1x
P/FCF ratio	35.9x
P/OCF ratio	31.75x
P/S ratio	10.83x
Price / tangible book value	7.27x
Price/EBITDA ratio	26.72x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	39%
EBITDA margin	40.52%
Effective tax rate	16.48%
FCF margin	29.2%
Gross margin	54.96%
Operating margin	39%
Pretax margin	41.9%
Profit margin	35%
Profit per employee	BRL 3.6M
Profitable quarters	8
Profitable years	1
Revenue per employee	BRL 10.2M
ROA	11.93%
ROA (5Y)	14.82%
ROCE	20.9%
ROE	23.54%
ROE (5Y)	19%
ROIC	28.8%
ROIC (5Y)	37.75%
SBC / revenue	5.47%
Tax / revenue	6.91%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	22.12%
EPS growth (Q)	8.02%
EPS growth (QoQ)	7.21%
EPS growth 3Y	9.92%
EPS growth 5Y	17.77%
EPS growth quarters	5
EPS growth years	1
FCF growth	8.47%
FCF growth (Q)	9.25%
FCF growth (QoQ)	-21.74%
FCF growth 3Y	-0.71%
FCF growth 5Y	16.39%
Gross profit growth	15.3%
Gross profit growth (Q)	17.23%
Gross profit growth 3Y	8.01%
Gross profit growth 5Y	11.52%
Net income growth	21.1%
Net income growth (Q)	6.48%
Net income growth (QoQ)	6.63%
Net income growth 3Y	9.4%
Net income growth 5Y	17.2%
Net income growth quarters	5
Net income growth years	1
OCF growth	11.61%
OCF growth (Q)	4.87%
OCF growth (QoQ)	-21.2%
OCF growth 3Y	1.81%
OCF growth 5Y	15.15%
Operating income growth	10.85%
Operating income growth (Q)	9.92%
Operating income growth 3Y	3.16%
Operating income growth 5Y	8.75%
Revenue growth	10.23%
Revenue growth (Q)	12.45%
Revenue growth (QoQ)	11.62%
Revenue growth 10Y	23.24%
Revenue growth 3Y	9.81%
Revenue growth 5Y	13.5%
Revenue growth quarters	33
Revenue growth years	11

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -2.6B
Depreciation and amortization	BRL 1B
EBIT	BRL 25.4B
EBITDA	BRL 26.4B
EPS	BRL 2.87
Financing cash flow	BRL -11.4B
Free cash flow	BRL 19.7B
Free cash flow minus SBC	BRL 16.1B
Gross profit	BRL 35.8B
Income taxes	BRL 4.5B
Investing cash flow	BRL -4.6B
Net borrowing	BRL -28.9M
Net cash flow	BRL 6.1B
Net income	BRL 22.8B
Operating cash flow minus SBC	BRL 18.7B
Operating income	BRL 25.4B
Revenue	BRL 65.2B
Stock-based compensation	BRL 3.6B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	11.58
Book value per share	BRL 414.06
Debt / EBITDA	0.37
Debt / equity	0.1
Debt / FCF	0.52
Goodwill	BRL 5.8B
Interest coverage	369.14
Long-term assets	BRL 74.9B
Long-term liabilities	BRL 16.1B
Net cash (debt)	BRL 60.4B
Net cash / market cap	8.56%
Net cash growth	11.07%
Net debt / EBITDA	-2.29
Net debt / equity	-0.58
Net debt / FCF	-3.07
Piotroski F-Score	5
Property, plant and equipment	BRL 17.8B
Shareholders' equity	BRL 104.9B
Tangible book value	BRL 97.1B
Tangible book value per share	BRL 383.37
Total assets	BRL 142.1B
Total cash	BRL 40.7B
Total debt	BRL 10.2B
Total liabilities	BRL 37.2B
WACC	5.72%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.49
Current assets	BRL 67.1B
Current liabilities	BRL 21.1B
Current ratio	3.19
Inventory turnover	3.47
Net working capital	BRL 3.9B
Quick ratio	2.54
Working capital	BRL 44.6B
Working capital turnover	8.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.85%
Shareholder yield	0.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 76.66
1D price change	4.44%
1M price change	1.72%
1M total return	1.72%
1W price change	8.64%
1W total return	8.64%
1Y price change	21.61%
1Y return CAGR	21.63%
1Y total return	21.61%
20-day SMA	BRL 81.95
200-day SMA	BRL 76.35
3M price change	15.99%
3M total return	15.99%
3Y price change	49.98%
3Y return CAGR	14.46%
3Y total return	49.98%
50-day SMA	BRL 83.58
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 89.01
52-week high date	2026-08-25
52-week low	BRL 65.18
52-week low date	2026-05-05
5Y price change	169.04%
5Y return CAGR	21.89%
5Y total return	169.04%
6M price change	28.61%
6M total return	28.61%
All-time high	BRL 93.56
All-time high date	2024-11-08
All-time low	BRL 20.29
All-time low date	2019-06-03
Average true range (ATR)	BRL 2.28
Average volume	371.5
Beta (5Y)	0.28
Change from 52-week high	-2.84%
Change from 52-week low	32.68%
Change from all-time high	-7.56%
Change from all-time low	326.14%
Change from open	0%
Day's gap	4.44%
Dollar volume	BRL 10,896
High price	BRL 86.48
Low price	BRL 86.48
Monthly RSI	59.91
Open price	BRL 86.48
Previous close	BRL 82.80
Price vs 150-day SMA	12.81%
Price vs 20-day SMA	5.53%
Price vs 200-day SMA	13.27%
Price vs 50-day SMA	3.47%
Relative volume	0.34
RSI	59.47
Sharpe ratio	0.3
Sharpe ratio (3Y)	0.57
Sharpe ratio (5Y)	0.55
Sortino ratio	0.55
Sortino ratio (3Y)	0.95
Sortino ratio (5Y)	0.95
Volume	126
Weekly RSI	59.23
YTD price change	10.53%
YTD total return	10.53%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	252.7M
Shares change (QoQ)	-0.43%
Shares change (YoY)	-0.85%
Shares held by insiders	0.2%
Shares held by institutions	97.11%
Short ratio	3.6 days

Deeper analysis on BVMF/VRTX34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/VRTX34 report

Is a complete BVMF/VRTX34 research report available?

No complete published report is available for bvmf/VRTX34 (BVMF/VRTX34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/VRTX34 (BVMF/VRTX34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/VRTX34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/VRTX34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/VRTX34

Frequently asked questions